The Times Australia
The Times News

.

AstraZeneca Vaccine Doses Arrive in Australia

  • Written by Scott Morrison


Signalling yet another major milestone in Australia’s response to the COVID-19 pandemic, 300,000 doses of the University of Oxford/AstraZeneca COVID-19 vaccine have arrived in Sydney today.

Australia has secured 53.8 million doses of the Oxford/AstraZeneca vaccine. The first doses of this vaccine have arrived from overseas ahead of 50 million doses to be manufactured by CSL here in Australia on behalf of AstraZeneca.

The Therapeutic Goods Administration (TGA) will now batch test the vaccines to ensure they meet Australia’s strict quality standards.

Prime Minister Scott Morrison said today was a significant milestone for the vaccine rollout.

“This is the next step as we ramp up the vaccine rollout,” the Prime Minister said.

“The University of Oxford/AstraZeneca vaccine will undergo the same rigorous TGA process to batch check the vaccine that the Pfizer/BioNTech vaccine underwent.

“We will now be able to scale up the vaccination rollout to our priority groups, including our most vulnerable Australians and to our frontline border and health workers.

“Most Australians will receive the University of Oxford/AstraZeneca vaccine, with the rollout of these due to commence from 8 March 2021 – provided they clear the TGA’s rigorous batch testing process.

“Australia is in a unique position because importantly this vaccine gives us the ability to manufacture onshore. Every Australian who wishes to be vaccinated will be able to receive a vaccine this year.”

The approximately 300,000 doses that arrived this morning will be distributed via logistics partners DHL and Linfox, and made available to priority groups in Phase 1a.

A further 50 million vaccines will be manufactured onshore and 1 million of these doses will be delivered each week from late March.

For AstraZeneca the second dose of the vaccine will be administered at 12 weeks after the first dose.

On 15 February 2021, the World Health Organization said, “This regimen was shown in clinical trials to be safe and effective in preventing symptomatic COVID-19, with no severe cases and no hospitalisations more than 14 days after the second dose.”

On 3 February 2021 the Lancet Journal said, “COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials.”

Minister for Health and Aged Care Greg Hunt said this vaccine provides the option for the majority of Australians to get their vaccination through their usual GP, local respiratory centre and eventually community pharmacies.

“Importantly the TGA has conducted a full and thorough, and world class assessment process,” Minister Hunt said.

“As the rollout begins, the people in priority groups who need the most protection will receive a vaccine first. This includes aged care and disability care residents and workers, frontline healthcare workers, and quarantine and border workers.

“Having AstraZeneca available in Australia provides an easier avenue for distribution across the nation, meaning people in rural, regional and remote areas will not have to travel as far to receive their vaccine.

“The cold chain requirements of this vaccine – it can be stored and handled in the same way as any other vaccine – make it a very good candidate for a country like Australia.

“As well, vaccine providers can use some of the vaccine vial, put the rest back in the fridge for 48 hours and use the rest the next day.

“This will save lives and protect lives.”

Australia has maintained a diverse portfolio of vaccines, and we are constantly engaging with international counterparts and vaccine sponsors to access the best available information on vaccine developments worldwide.

Pending TGA approval, the Government has also secured 51 million doses of the Novavax vaccine.

The Australian Government has also signed up to the international COVAX facility, which provides access to a range of vaccines to immunise up to 50 per cent of the Australian population.

This diverse portfolio ensures access for everyone in Australia, and is likely to equip us to support our neighbours in the Pacific and Southeast Asia.

The University of Oxford/AstraZeneca vaccine is the second vaccine to receive provisional approval for use in Australia by the TGA. The TGA bases such decisions on the safety, efficacy and quality of the vaccine candidates.

Times Magazine

Headless CMS in Digital Twins and 3D Product Experiences

Image by freepik As the metaverse becomes more advanced and accessible, it's clear that multiple sectors will use digital twins and 3D product experiences to visualize, connect, and streamline efforts better. A digital twin is a virtual replica of ...

The Decline of Hyper-Casual: How Mid-Core Mobile Games Took Over in 2025

In recent years, the mobile gaming landscape has undergone a significant transformation, with mid-core mobile games emerging as the dominant force in app stores by 2025. This shift is underpinned by changing user habits and evolving monetization tr...

Understanding ITIL 4 and PRINCE2 Project Management Synergy

Key Highlights ITIL 4 focuses on IT service management, emphasising continual improvement and value creation through modern digital transformation approaches. PRINCE2 project management supports systematic planning and execution of projects wit...

What AI Adoption Means for the Future of Workplace Risk Management

Image by freepik As industrial operations become more complex and fast-paced, the risks faced by workers and employers alike continue to grow. Traditional safety models—reliant on manual oversight, reactive investigations, and standardised checklist...

From Beach Bops to Alpine Anthems: Your Sonos Survival Guide for a Long Weekend Escape

Alright, fellow adventurers and relaxation enthusiasts! So, you've packed your bags, charged your devices, and mentally prepared for that glorious King's Birthday long weekend. But hold on, are you really ready? Because a true long weekend warrior kn...

Effective Commercial Pest Control Solutions for a Safer Workplace

Keeping a workplace clean, safe, and free from pests is essential for maintaining productivity, protecting employee health, and upholding a company's reputation. Pests pose health risks, can cause structural damage, and can lead to serious legal an...

The Times Features

Tricia Paoluccio designer to the stars

The Case for Nuturing Creativity in the Classroom, and in our Lives I am an actress and an artist who has had the privilege of sharing my work across many countries, touring my ...

Duke of Dural to Get Rooftop Bar as New Owners Invest in Venue Upgrade

The Duke of Dural, in Sydney’s north-west, is set for a major uplift under new ownership, following its acquisition by hospitality group Good Beer Company this week. Led by resp...

Prefab’s Second Life: Why Australia’s Backyard Boom Needs a Circular Makeover

The humble granny flat is being reimagined not just as a fix for housing shortages, but as a cornerstone of circular, factory-built architecture. But are our systems ready to s...

Melbourne’s Burglary Boom: Break-Ins Surge Nearly 25%

Victorian homeowners are being warned to act now, as rising break-ins and falling arrest rates paint a worrying picture for suburban safety. Melbourne residents are facing an ...

Exploring the Curriculum at a Modern Junior School in Melbourne

Key Highlights The curriculum at junior schools emphasises whole-person development, catering to children’s physical, emotional, and intellectual needs. It ensures early year...

Distressed by all the bad news? Here’s how to stay informed but still look after yourself

If you’re feeling like the news is particularly bad at the moment, you’re not alone. But many of us can’t look away – and don’t want to. Engaging with news can help us make ...